Short-acting to extended half-life, Ireland signs exclusive haemophilia deal
The Republic of Ireland will move its population from short-acting to extended half-life haemophilia therapies, under an exclusive two-year deal with Sobi.
Archives for February 14, 2018
Remediation and modernisation plans: Bayer responds to FDA warning
Bayer expects some temporary supply limitations affecting its mature product portfolio as it addresses GMP issues raised in a US FDA warning.
MSD repurposing dormant Irish site and hiring 350 to support Keytruda
Merck Sharp & Dohme (MSD) plans to build a biologics facility at a former small molecule manufacturing site in Swords, Ireland, which it closed last year.
SCOPE 2018
Clinerion joins BlueCloud: 'Data is becoming the new oil'
HealthCarePoint has announced a mutual collaboration with Clinerion through which members of the company’s BlueCloud Sponsor Network will gain access to Clinerion’s patient database via a dynamic map.
Industry donates ‘one-shot’ anti-opioid delivery tech to Illinois
AptarGroup has donated its nasal spray delivery technology to the Illinois Task Force in conjunction with opioid antagonist maker Adapt Pharma.
SCOPE 2018
Parexel teams with BioFortis to offer biological sample lifecycle management services
Parexel has launched a new offering that enables customers to manage patient biological sample assets across the supply chain, as precision medicine becomes more prominent, says VP.
UPDATE
Pfizer Finland taps biobank network for trials
Pfizer will access data and samples for clinical trials using BC Platform’s global biobank network.